Maraviroc is an antiretroviral drug in the CCR5 receptor antagonist class used in the treatment of HIV infection.
Market Analysis and Insights: Global Maraviroc Market
The global Maraviroc market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Maraviroc is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Maraviroc is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Maraviroc is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Maraviroc include ViiV Healthcare, SANDOZ and HETERO, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Maraviroc market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Maraviroc, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Maraviroc, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Maraviroc revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Maraviroc market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Maraviroc revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including ViiV Healthcare, SANDOZ and HETERO, etc.
By Company
ViiV Healthcare
SANDOZ
HETERO
Segment by Type
25 mg Tablets
75 mg Tablets
150 mg Tablets
300 mg Tablets
20 mg/mL Oral Solution
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Maraviroc in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Maraviroc companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Maraviroc revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Maraviroc Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 25 mg Tablets
1.2.3 75 mg Tablets
1.2.4 150 mg Tablets
1.2.5 300 mg Tablets
1.2.6 20 mg/mL Oral Solution
1.3 Market by Application
1.3.1 Global Maraviroc Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drug store
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Maraviroc Market Perspective (2018-2029)
2.2 Global Maraviroc Growth Trends by Region
2.2.1 Maraviroc Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Maraviroc Historic Market Size by Region (2018-2023)
2.2.3 Maraviroc Forecasted Market Size by Region (2024-2029)
2.3 Maraviroc Market Dynamics
2.3.1 Maraviroc Industry Trends
2.3.2 Maraviroc Market Drivers
2.3.3 Maraviroc Market Challenges
2.3.4 Maraviroc Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Maraviroc by Players
3.1.1 Global Maraviroc Revenue by Players (2018-2023)
3.1.2 Global Maraviroc Revenue Market Share by Players (2018-2023)
3.2 Global Maraviroc Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Maraviroc, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Maraviroc Market Concentration Ratio
3.4.1 Global Maraviroc Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Maraviroc Revenue in 2022
3.5 Global Key Players of Maraviroc Head office and Area Served
3.6 Global Key Players of Maraviroc, Product and Application
3.7 Global Key Players of Maraviroc, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Maraviroc Breakdown Data by Type
4.1 Global Maraviroc Historic Market Size by Type (2018-2023)
4.2 Global Maraviroc Forecasted Market Size by Type (2024-2029)
5 Maraviroc Breakdown Data by Application
5.1 Global Maraviroc Historic Market Size by Application (2018-2023)
5.2 Global Maraviroc Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Maraviroc Market Size (2018-2029)
6.2 North America Maraviroc Market Size by Type
6.2.1 North America Maraviroc Market Size by Type (2018-2023)
6.2.2 North America Maraviroc Market Size by Type (2024-2029)
6.2.3 North America Maraviroc Market Share by Type (2018-2029)
6.3 North America Maraviroc Market Size by Application
6.3.1 North America Maraviroc Market Size by Application (2018-2023)
6.3.2 North America Maraviroc Market Size by Application (2024-2029)
6.3.3 North America Maraviroc Market Share by Application (2018-2029)
6.4 North America Maraviroc Market Size by Country
6.4.1 North America Maraviroc Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Maraviroc Market Size by Country (2018-2023)
6.4.3 North America Maraviroc Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Maraviroc Market Size (2018-2029)
7.2 Europe Maraviroc Market Size by Type
7.2.1 Europe Maraviroc Market Size by Type (2018-2023)
7.2.2 Europe Maraviroc Market Size by Type (2024-2029)
7.2.3 Europe Maraviroc Market Share by Type (2018-2029)
7.3 Europe Maraviroc Market Size by Application
7.3.1 Europe Maraviroc Market Size by Application (2018-2023)
7.3.2 Europe Maraviroc Market Size by Application (2024-2029)
7.3.3 Europe Maraviroc Market Share by Application (2018-2029)
7.4 Europe Maraviroc Market Size by Country
7.4.1 Europe Maraviroc Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Maraviroc Market Size by Country (2018-2023)
7.4.3 Europe Maraviroc Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Maraviroc Market Size (2018-2029)
8.2 China Maraviroc Market Size by Type
8.2.1 China Maraviroc Market Size by Type (2018-2023)
8.2.2 China Maraviroc Market Size by Type (2024-2029)
8.2.3 China Maraviroc Market Share by Type (2018-2029)
8.3 China Maraviroc Market Size by Application
8.3.1 China Maraviroc Market Size by Application (2018-2023)
8.3.2 China Maraviroc Market Size by Application (2024-2029)
8.3.3 China Maraviroc Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Maraviroc Market Size (2018-2029)
9.2 Asia Maraviroc Market Size by Type
9.2.1 Asia Maraviroc Market Size by Type (2018-2023)
9.2.2 Asia Maraviroc Market Size by Type (2024-2029)
9.2.3 Asia Maraviroc Market Share by Type (2018-2029)
9.3 Asia Maraviroc Market Size by Application
9.3.1 Asia Maraviroc Market Size by Application (2018-2023)
9.3.2 Asia Maraviroc Market Size by Application (2024-2029)
9.3.3 Asia Maraviroc Market Share by Application (2018-2029)
9.4 Asia Maraviroc Market Size by Region
9.4.1 Asia Maraviroc Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Maraviroc Market Size by Region (2018-2023)
9.4.3 Asia Maraviroc Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Maraviroc Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Maraviroc Market Size by Type
10.2.1 Middle East, Africa, and Latin America Maraviroc Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Maraviroc Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Maraviroc Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Maraviroc Market Size by Application
10.3.1 Middle East, Africa, and Latin America Maraviroc Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Maraviroc Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Maraviroc Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Maraviroc Market Size by Country
10.4.1 Middle East, Africa, and Latin America Maraviroc Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Maraviroc Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Maraviroc Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 ViiV Healthcare
11.1.1 ViiV Healthcare Company Details
11.1.2 ViiV Healthcare Business Overview
11.1.3 ViiV Healthcare Maraviroc Introduction
11.1.4 ViiV Healthcare Revenue in Maraviroc Business (2018-2023)
11.1.5 ViiV Healthcare Recent Developments
11.2 SANDOZ
11.2.1 SANDOZ Company Details
11.2.2 SANDOZ Business Overview
11.2.3 SANDOZ Maraviroc Introduction
11.2.4 SANDOZ Revenue in Maraviroc Business (2018-2023)
11.2.5 SANDOZ Recent Developments
11.3 HETERO
11.3.1 HETERO Company Details
11.3.2 HETERO Business Overview
11.3.3 HETERO Maraviroc Introduction
11.3.4 HETERO Revenue in Maraviroc Business (2018-2023)
11.3.5 HETERO Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
ViiV Healthcare
SANDOZ
HETERO
*If Applicable.